Belgian 3D printing leader, Materialise has announced a collaboration with DePuy Synthes to offer its patient-specific, craniomaxillofacial (CMF) implants through DePuy Synthes TRUMATCH CMF Solutions in Australia and Europe.
The TRUMATCH CMF solution currently includes ProPlan CMF, a Materialise and DePuy Synthes solution for planning and patient-specific guides for CMF surgery. These custom implants will be available throughout both regions, excluding France. Patient-specific implants are not yet commercially available in the US and Canada.
Materialise Founder and CEO, Wilfried Vancraen, stated, “At Materialise, we strive to make medical 3D printing accessible to every researcher, engineer, and clinician, through an open platform of software and services that help customise patient treatment. Together with DePuy Synthes, we have successfully enabled better surgical outcomes through surgical planning and patient-specific guides, and are proud that this new collaboration will now empower even more CMF surgeons to discover the benefits of 3D-printed, patient-specific implants as well.”
DePuy Synthes is part of the Johnson & Johnson family and offers the world’s most comprehensive portfolio of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials.
Materialise has 25 years of experience in 3D planning and printing for medical applications including the development of dedicated 3D visualisation and planning software, engineering and design services and the production of 3D printed patient-specific guides and implants. In the field of CMF surgery, Materialise offers customised solutions that are tailored to the specific needs of each individual patient.